GC Therapeutics Wants to Turn a Four-Day Cell Recipe Into Medicine at Scale

The Harvard spinout says its TFome platform can compress months of stem-cell differentiation into four days. Now it has to prove that programmable cells can survive the far harder journey from an elegant recipe to an approved medicine.